An open science pathway for drug marketing authorization-Registered drug approval

PLoS Med. 2021 Aug 9;18(8):e1003726. doi: 10.1371/journal.pmed.1003726. eCollection 2021 Aug.

Abstract

Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Approval / methods*
  • Drug Approval / organization & administration
  • European Union*
  • Marketing
  • Pharmaceutical Preparations

Substances

  • Pharmaceutical Preparations